Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 36

1.

Adherence to antiretroviral therapy in children attending Mulago Hospital, Kampala.

Nabukeera-Barungi N, Kalyesubula I, Kekitiinwa A, Byakika-Tusiime J, Musoke P.

Ann Trop Paediatr. 2007 Jun;27(2):123-31.

PMID:
17565809
2.

Patient, caregiver and regimen characteristics associated with adherence to highly active antiretroviral therapy among HIV-infected children and adolescents.

Martin S, Elliott-DeSorbo DK, Wolters PL, Toledo-Tamula MA, Roby G, Zeichner S, Wood LV.

Pediatr Infect Dis J. 2007 Jan;26(1):61-7.

PMID:
17195708
3.

Clinical outcomes improve with highly active antiretroviral therapy in vertically HIV type-1-infected children.

Resino S, Resino R, Maria Bellón J, Micheloud D, Gutiérrez MD, de José MI, Ramos JT, Fontelos PM, Ciria L, Muñoz-Fernández MA; Spanish Group of Pediatric HIV Infection.

Clin Infect Dis. 2006 Jul 15;43(2):243-52. Epub 2006 Jun 9.

PMID:
16779753
4.

Adherence to antiretroviral therapy: an empirical test of the information-motivation-behavioral skills model.

Starace F, Massa A, Amico KR, Fisher JD.

Health Psychol. 2006 Mar;25(2):153-62.

PMID:
16569106
5.

Improving adherence to antiretroviral therapy.

Nischal KC, Khopkar U, Saple DG.

Indian J Dermatol Venereol Leprol. 2005 Sep-Oct;71(5):316-20. Review.

6.

Causes of the decline in AIDS deaths, United States, 1995-2002: prevention, treatment or both?

Holtgrave DR.

Int J STD AIDS. 2005 Dec;16(12):777-81. Review.

PMID:
16336756
7.

Vitamin supplements, socioeconomic status, and morbidity events as predictors of wasting in HIV-infected women from Tanzania.

Villamor E, Saathoff E, Manji K, Msamanga G, Hunter DJ, Fawzi WW.

Am J Clin Nutr. 2005 Oct;82(4):857-65.

8.

Home-based therapy with ready-to-use therapeutic food is of benefit to malnourished, HIV-infected Malawian children.

Ndekha MJ, Manary MJ, Ashorn P, Briend A.

Acta Paediatr. 2005 Feb;94(2):222-5.

PMID:
15981758
9.

The role of psychosocial and family factors in adherence to antiretroviral treatment in human immunodeficiency virus-infected children.

Mellins CA, Brackis-Cott E, Dolezal C, Abrams EJ.

Pediatr Infect Dis J. 2004 Nov;23(11):1035-41.

PMID:
15545859
10.

A randomized trial of multivitamin supplements and HIV disease progression and mortality.

Fawzi WW, Msamanga GI, Spiegelman D, Wei R, Kapiga S, Villamor E, Mwakagile D, Mugusi F, Hertzmark E, Essex M, Hunter DJ.

N Engl J Med. 2004 Jul 1;351(1):23-32.

11.

Disclosure model for pediatric patients living with HIV in Puerto Rico: design, implementation, and evaluation.

Blasini I, Chantry C, Cruz C, Ortiz L, Salabarría I, Scalley N, Matos B, Febo I, Díaz C.

J Dev Behav Pediatr. 2004 Jun;25(3):181-9.

PMID:
15194903
12.
13.

Adherence to antiretroviral therapy and its determinants in children with human immunodeficiency virus infection: a multicentre, national study.

Giacomet V, Albano F, Starace F, de Franciscis A, Giaquinto C, Gattinara GC, Bruzzese E, Gabiano C, Galli L, Viganò A, Caselli D, Guarino A.

Acta Paediatr. 2003 Dec;92(12):1398-402.

PMID:
14971789
14.
15.

Adherence to prescribed antiretroviral therapy in human immunodeficiency virus-infected children in the PENTA 5 trial.

Gibb DM, Goodall RL, Giacomet V, McGee L, Compagnucci A, Lyall H; Paediatric European Network for Treatment of AIDS Steering Committee.

Pediatr Infect Dis J. 2003 Jan;22(1):56-62.

PMID:
12544410
16.

Achieving adherence with antiretroviral medications for pediatric HIV disease.

Byrne M, Honig J, Jurgrau A, Heffernan SM, Donahue MC.

AIDS Read. 2002 Apr;12(4):151-54, 161-4.

PMID:
12071185
17.

Reported adherence as a determinant of response to highly active antiretroviral therapy in children who have human immunodeficiency virus infection.

Van Dyke RB, Lee S, Johnson GM, Wiznia A, Mohan K, Stanley K, Morse EV, Krogstad PA, Nachman S; Pediatric AIDS Clinical Trials Group Adherence Subcommittee Pediatric AIDS Clinical Trials Group 377 Study Team.

Pediatrics. 2002 Apr;109(4):e61.

PMID:
11927734
18.

Results of 2 years of treatment with protease-inhibitor--containing antiretroviral therapy in dutch children infected with human immunodeficiency virus type 1.

van Rossum AM, Geelen SP, Hartwig NG, Wolfs TF, Weemaes CM, Scherpbier HJ, van Lochem EG, Hop WC, Schutten M, Osterhaus AD, Burger DM, de Groot R.

Clin Infect Dis. 2002 Apr 1;34(7):1008-16. Epub 2002 Mar 4.

PMID:
11880968
19.

Impact of antiretroviral protocols on dynamics of AIDS progression markers.

Resino S, Bellón JM, Sánchez-Ramón S, Gurbindo D, Ruiz-Contreras J, León JA, Ramos JT, Muñóz-Fernández MA.

Arch Dis Child. 2002 Feb;86(2):119-24.

20.

Effect of combination therapy including protease inhibitors on mortality among children and adolescents infected with HIV-1.

Gortmaker SL, Hughes M, Cervia J, Brady M, Johnson GM, Seage GR 3rd, Song LY, Dankner WM, Oleske JM; Pediatric AIDS Clinical Trials Group Protocol 219 Team.

N Engl J Med. 2001 Nov 22;345(21):1522-8.

Supplemental Content

Support Center